Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias

Author： Thakkar S.   Isada C.   Smith J.   Karam M.   Reed J.   Tomford J.   Englund K.   Richmond M.   Licata A.   Hatch C.   Hussein M.  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.23, Iss.1, 2006-03, pp. : 51-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

By Walter Christian   Grötz Knut   Kunkel Martin   Al-Nawas Bilal  

Supportive Care in Cancer, Vol. 15, Iss. 2, 2007-02 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite

Jaw complications in breast and prostate cancer patients treated with zoledronic acid

By Ortega C.   Faggiuolo R.   Vormola R.   Montemurro F.   Nanni D.   Goia F.   Aglietta M.  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 216-217

Informa Healthcare

Access to resources Recommend Favorite

The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates

By Sanna G.   Preda L.   Bruschini R.   Cossu Rocca M.   Verri E.   Bellomi M.   Goldhirsch A.   Nole F.  

Acta Oncologica, Vol. 47, Iss. 3, 2007-09 ,pp. : 476-478

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonate Therapy for Patients with Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 3, 2005-01 ,pp. : 217-225

Bentham Science Publishers

Access to resources Recommend Favorite

Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study

By      

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 859-866

Spandidos Publications

Access to resources Recommend Favorite